http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005005600-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e117862d09978913d964c517c974c15e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0f4246e8fcebf17c365aced017a04c61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89b6c8adbf8a34d96fd7950e1fc58741
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ed7b8841b37334dc53413e3397bb174
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14
filingDate 2004-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d8ca7f56784e562456015aea6b86a10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86d3cedded0a1343d9b7b312725be77a
publicationDate 2005-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005005600-A3
titleOfInvention Camptothecin analogs having an e-ring ketone
abstract Camptothecin analogs having an E-ring ketone are effective anti tumor compounds. These compounds inhibit the enzyme topoisomerase I and may alkylate DNA of the associated topoisomerase I DNA cleavable complex.
priorityDate 2003-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6509345-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1101765-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6043367-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397589
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481343
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24360

Total number of triples: 22.